Development of Novel Antimicrobial Resistance Agents

Information

• Research Project
• 8161307

• ApplicationId

  8161307

• Core Project Number

  272200800043C-2-0-1

• Full Project Number

  272200800043C-2-0-1

• Serial Number

  0

• FOA Number

• Sub Project Id

• Project Start Date

  9/1/2008 - 16 years ago

• Project End Date

  8/31/2013 - 11 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2010

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• Achaogen, Inc.

This contract supports the advanced development of a novel antibacterial for the treatment of Gram-negative pathogens. The scope of work for this contract includes discovery, preclinical/non-clinical development activities, IND-enabling activities, and Phase I clinical trials.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  5697418

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:5697418\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  ACHAOGEN, INC.

• Organization Department

• Organization DUNS

  167293153

• Organization City

  SOUTH SAN FRANCISCO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  940801945

• Organization District

  UNITED STATES